Clinical trial

A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients

NCT00653406

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-11-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2002-11-01Date precision: month

Registry last updated2011-05-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Risperidone long acting injectableDRUG

Sponsors & collaborators

Janssen Pharmaceutical K.K.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00653406 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.